Skip to content

RRR Study: study on the role of inhibitory receptors in respiratory syncytial virus (RSV) bronchiolitis

RRR Study: study on the role of inhibitory receptors in respiratory syncytial virus (RSV) bronchiolitis - RRR Study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34523
Enrollment
Unknown
Registered
2011-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchiolitis luchtwegontsteking

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Children under the age of 13 months that require mechanical ventilation for symptoms of respiratory syncytial virus (RSV) lower respiratory infection, known as the index group. In addition, 3 control populations will included: hospitalized RSV patients who do not require mechanical ventilation, ventilated control patients without infection and non-ventilated control patients without infection

Exclusion criteria

Exclusion criteria: Severe comorbidity, such as any organ dysfunction Any Syndromal abnormality, such as Down Syndrome Any other infection during past 14 days

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: (1) expression of inhibitory receptors in peripheral blood and tracheal aspirate, (2) concentration of soluble inhibitory receptors in plasma, nasopharyngeal aspirates and urine.

Secondary

MeasureTime frame
A secondary objective is to study changes in bacterial carriership during the course of infection, which will be studied in nasopharyngeal swabs on admission and 1 month later.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)